Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Mental health

Son Sees Early Signs Of Alzheimer’s 25 Years Before Diagnosis

A man's father diagnosed with Alzheimer's after 2021 brain scan, but son noticed changes in concentration levels decades earlier.

Zenger

Researchers issue new guidelines for diagnosing Alzheimer's

New guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented at the International Alzheimer's Congress (AAIC) in Amsterdam. Read further on Dynamite News:

Dynamite News

Alzheimer’s most prevalent in US east and south-east, first-of-its-kind study finds

Study, which used cognitive data and population estimates, examines prevalence of the disease by county

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

ADHD meds don't predict drug use: study

New research in JAMA Psychiatry found no association between taking Ritalin and struggling with substance use

Salon

London is the most sleepless city in the country, new insomnia study finds

The capital has the highest number of people being referred for sleep problems in England

Evening Standard

Alzheimer’s rates highest in Texas border counties, new study shows

Texas’ border counties have higher rates of Alzheimer’s disease among older adults than other areas in the state, according to a new study estimating county-level prevalence of the neurodegenerative disease.

Tribune News Service

Link between hearing aids and dementia revealed

The study highlights the importance of treating hearing loss in older people as a potential way to reduce the global burden of the condition

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

‘Hearing aids might reduce cognitive decline in adults at higher dementia risk’

The study highlights the importance of treating hearing loss in older people as a potential way to reduce the global burden of the condition

The Independent UK

Up to 3m UK people behind on bills have had mental health problems, study says

People with recent mental health issues three times more likely to be behind on at least one key bill, research finds

The Guardian - UK

Third day of Oval Ashes Test to be dedicated to Alzheimer’s Society

The dementia charity are hoping to raise awareness and funds for the disease.

The Independent UK

Why is this Alzheimer’s breakthrough so important?

Your questions answered on donanemab.

The Independent UK

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Everything we know about breakthrough Alzheimer’s drug Donanemab

Alzheimer’s disease is the most common cause of dementia in the UK

The Independent UK

Repetitive heading again linked to cognitive impairment, study suggests

The findings from the second part of the FOCUS study were published on Monday.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

The Independent UK

‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

The Independent UK

Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern

New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening

WEKU

An experimental Alzheimer's drug outperforms one just approved by the FDA

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

What impact will Alzheimer’s drug donanemab have?

While it is not a cure, proof that drugs can alter course of disease is regarded as significant triumph

The Guardian - UK

Experts urge health regulators to approve ‘turning point’ dementia drugs

Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial

Tribune News Service

Ask the Pediatrician: What is single-sided deafness in children?

Single-sided deafness (SSD) is a hearing impairment that affects at least one in every 1,000 babies born. These infants have severe-to-profound hearing loss in one ear with normal or near-normal hearing in the other ear. The condition can also develop in older children and adults.

The Hindu

Radio Khanchi hit among the students in Ranchi

Ranchi Univ. has its own Radio Khanchi 90.4 FM, providing academic info & lectures to students. It also focuses on health & society awareness campaigns.

The Guardian - AU

Is sleep the canary in the coalmine – a clue to the health of our minds?

Sleep disturbance is a recognised risk factor for developing a host of psychiatric disorders. Going to bed is the best thing you can do for your brain right now

Chicago Sun-Times

Dear Abby: Some relatives never visited my father with Alzheimer’s

Disappointed reader concludes that either they didn’t care, no one cared, or they were for some reason afraid to see someone with the disease

Tribune News Service

New Alzheimer’s drug is first to show it slows disease. But It’s facing a rocky rollout

Eisai Co.’s breakthrough Alzheimer’s drug — the first to show it slows the brain-destroying disease — is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and complicated safety testing requirements.

1 … 45 46 47 48

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

103 stories

Johns Hopkins University

Eli Lilly and Company

49 stories

JAMA

33 stories

the Alzheimer Association

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.